{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:47:58Z","timestamp":1770742078113,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R15HD092931"],"award-info":[{"award-number":["R15HD092931"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bone.2022.116542","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T12:29:10Z","timestamp":1661603350000},"page":"116542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effects of bisphosphonates on appendicular fracture repair in rodents"],"prefix":"10.1016","volume":"164","author":[{"given":"Michael","family":"Hadjiargyrou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.bone.2022.116542_bb0005","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.3390\/ijms21207623","article-title":"Molecular mechanisms and emerging therapeutics for osteoporosis","volume":"21","author":"Noh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2022.116542_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1365.035","article-title":"Bone remodeling","volume":"1092","author":"Hadjidakis","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2022.116542_bb0020","first-page":"640878","article-title":"Whole-body versus local DXA-scan for the diagnosis of osteoporosis in COPD patients","author":"Graat-Verboom","year":"2010","journal-title":"J. Osteoporos."},{"issue":"1","key":"10.1016\/j.bone.2022.116542_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-824X-5-1","article-title":"Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect","volume":"14;5","author":"Sharma","year":"2013","journal-title":"Vasc. Cell"},{"issue":"4","key":"10.1016\/j.bone.2022.116542_bb0035","first-page":"331","article-title":"Controversies in the treatment of postmenopausal osteoporosis: how long to treat with bisphosphonates?","volume":"64","author":"Bandeira","year":"2020","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2022.116542_bb0040","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.bone.2015.08.020","article-title":"The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants","volume":"81","author":"Tsoumpra","year":"2015","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2022.116542_bb0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0009-9236(95)90245-7","article-title":"Studies of the oral bioavailability of alendronate","volume":"58","author":"Gertz","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bone.2022.116542_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","article-title":"Bisphosphonates: a review of their pharmacokinetic properties","volume":"18","author":"Lin","year":"1996","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2022.116542_bb0055","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bone.2007.12.225","article-title":"Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells","volume":"42","author":"Coxon","year":"2008","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2022.116542_bb0060","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/bcp.13867","article-title":"Pharmacology of bisphosphonates","volume":"85","author":"Cremers","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.bone.2022.116542_bb0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MED.0000000000000287","article-title":"Bisphosphonates and atypical femoral fractures","volume":"23","author":"Adler","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.bone.2022.116542_bb0070","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116542_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2022.116542_bb0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MED.0000000000000287","article-title":"Bisphosphonates and atypical femoral fractures","volume":"23","author":"Adler","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"33","key":"10.1016\/j.bone.2022.116542_bb0085","doi-asserted-by":"crossref","first-page":"30177","DOI":"10.1074\/jbc.M203171200","article-title":"Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair","volume":"277","author":"Hadjiargyrou","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bone.2022.116542_bb0090","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bone.2003.12.024","article-title":"Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair","volume":"34","author":"Komatsu","year":"2004","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2022.116542_bb0095","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/jbmr.061207","article-title":"Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiency","volume":"22","author":"Komatsu","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2022.116542_bb0100","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/jbmr.2373","article-title":"The convergence of fracture repair and stem cells: interplay of genes, aging, environmental factors and disease","volume":"29","author":"Hadjiargyrou","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2022.116542_bb0110","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-0773.1994.tb00379.x","article-title":"The influence of dichloromethylene bisphosphonate on the healing of a long bone fracture, composition of bone mineral and histology of bone in the rat","volume":"75","author":"Hyv\u00f6nen","year":"1994","journal-title":"Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.bone.2022.116542_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00573453","article-title":"Healing of a tibial double osteotomy is modified by clodronate administration","volume":"115","author":"Nyman","year":"1996","journal-title":"Arch. Orthop. Trauma Surg."},{"issue":"5","key":"10.1016\/j.bone.2022.116542_bb0120","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3109\/17453679808997793","article-title":"No adverse effects of clodronate on fracture healing in rats","volume":"69","author":"Madsen","year":"1998","journal-title":"Acta Orthop. Scand."},{"key":"10.1016\/j.bone.2022.116542_bb0125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00003086-200303000-00036","article-title":"Long-term administration of clodronate does not prevent fracture healing in rats","volume":"408","author":"Koivukangas","year":"2003","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"6","key":"10.1016\/j.bone.2022.116542_bb0130","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1359\/jbmr.1999.14.6.969","article-title":"Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats","volume":"14","author":"Li","year":"1999","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.bone.2022.116542_bb0135","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1359\/jbmr.2000.15.10.2042","article-title":"Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats","volume":"15","author":"Li","year":"2000","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2022.116542_bb0140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/jbmr.2001.16.3.429","article-title":"Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats","volume":"16","author":"Li","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2022.116542_bb0145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/aps.2012.170","article-title":"Long-term effects of alendronate on fracture healing and bone remodeling of femoral shaft in ovariectomized rats","volume":"34","author":"Fu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.bone.2022.116542_bb0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5312\/wjo.v9.i10.190","article-title":"Dose of alendronate directly increases trabeculae expansivity without altering bone volume in rat femurs","volume":"9","author":"Weiss","year":"2018","journal-title":"World J. Orthop."},{"issue":"9","key":"10.1016\/j.bone.2022.116542_bb0155","article-title":"Effect of age and sodium alendronate on femoral fracture repair: biochemical and biomechanical study in rats","volume":"5","author":"Bonetto","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.bone.2022.116542_bb0160","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.orthres.2005.03.004","article-title":"A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair","volume":"23","author":"Amanat","year":"2005","journal-title":"J. Orthop. Res."},{"issue":"17","key":"10.1016\/j.bone.2022.116542_bb0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12891-016-1113-9","article-title":"Local pamidronate influences fracture healing in a rodent femur fracture model: an experimental study","volume":"9","author":"Menzdorf","year":"2016","journal-title":"BMC Musculoskelet. Disord."},{"issue":"2","key":"10.1016\/j.bone.2022.116542_bb0170","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00223-019-00615-z","article-title":"Pretreatment with pamidronate decreases bone formation but increases callus bone volume in a rat closed fracture model","volume":"106","author":"Morse","year":"2020","journal-title":"Calcif. Tissue Int."},{"issue":"6","key":"10.1016\/j.bone.2022.116542_bb0175","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1359\/jbmr.070318","article-title":"Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair","volume":"22","author":"Amanat","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2022.116542_bb0180","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bone.2008.05.019","article-title":"Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling","volume":"43","author":"McDonald","year":"2008","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2022.116542_bb0185","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/17453670810016768","article-title":"Local application of zoledronic acid incorporated in a poly(D, L-lactide)-coated implant accelerates fracture healing in rats","volume":"79","author":"Greiner","year":"2008","journal-title":"Acta Orthop."},{"key":"10.1016\/j.bone.2022.116542_bb0190","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bone.2015.09.018","article-title":"Zoledronic acid suppresses callus remodeling but enhances callus strength in an osteoporotic rat model of fracture healing","volume":"81","author":"Hao","year":"2015","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2022.116542_bb0195","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1302\/0301-620X.95B9.31562","article-title":"Do bisphosphonates inhibit direct fracture healing?: a laboratory investigation using an animal model","volume":"95-B","author":"Savaridas","year":"2013","journal-title":"Bone Joint J."},{"issue":"11","key":"10.1016\/j.bone.2022.116542_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187683","article-title":"Local application of an ibandronate\/collagen sponge improves femoral fracture healing in ovariectomized rats","volume":"12","author":"Guo","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bone.2022.116542_bb0205","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1111\/os.13158","article-title":"Dynamic effects of the third generation bisphosphonate of risedronate on rat osteoporotic fractures for clinical usage guidance","volume":"13","author":"Ke","year":"2021","journal-title":"Orthop. Surg."},{"issue":"12","key":"10.1016\/j.bone.2022.116542_bb0210","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1359\/jbmr.2002.17.12.2237","article-title":"Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats","volume":"17","author":"Cao","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2022.116542_bb0215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00223-009-9318-7","article-title":"Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?","volume":"86","author":"Kolios","year":"2010","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.bone.2022.116542_bb0220","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bone.2011.07.005","article-title":"Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model","volume":"49","author":"Doi","year":"2011","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2022.116542_bb0225","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00198-011-1751-6","article-title":"The effects of combined human parathyroid hormone (1\u201334) and zoledronic acid treatment on fracture healing in osteoporotic rats","volume":"23","author":"Li","year":"2012","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.bone.2022.116542_bb0230","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/jbmr.2424","article-title":"PTH(1\u201334) treatment increases bisphosphonate turnover in fracture repair in rats","volume":"30","author":"Murphy","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2022.116542_bb0235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13018-018-0917-8","article-title":"Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model","volume":"13","author":"Tsubouchi","year":"2018","journal-title":"J. Orthop. Surg. Res."},{"issue":"1","key":"10.1016\/j.bone.2022.116542_bb0240","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41598-018-19296-z","article-title":"The compositional and nano-structural basis of fracture healing in healthy and osteoporotic bone","volume":"8","author":"Mathavan","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bone.2022.116542_bb0245","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/jor.24632","article-title":"Longitudinal in vivo monitoring of callus remodeling in BMP-7- and zoledronate-treated fractures","volume":"38","author":"Mathavan","year":"2020","journal-title":"J. Orthop. Res."},{"issue":"11","key":"10.1016\/j.bone.2022.116542_bb0250","doi-asserted-by":"crossref","DOI":"10.1590\/acb361107","article-title":"Effects of ergosteroside combined risedronate on fracture healing and BMP-2, BMP-7 and VEGF expression in rats","volume":"36","author":"Xu","year":"2021","journal-title":"Acta Cir. Bras."},{"issue":"2","key":"10.1016\/j.bone.2022.116542_bb0255","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1359\/jbmr.081113","article-title":"Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing","volume":"24","author":"Gerstenfeld","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2022.116542_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031771","article-title":"Site specific effects of zoledronic acid during tibial and mandibular fracture repair","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bone.2022.116542_bb0265","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bone.2013.06.003","article-title":"Fracture healing with alendronate treatment in the Brtl\/+ mouse model of osteogenesis imperfecta","volume":"56","author":"Meganck","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116542_bb0270","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bone.2016.08.012","article-title":"Effect of combined treatment with zoledronic acid and parathyroid hormone on mouse bone callus structure and composition","volume":"92","author":"Casanova","year":"2016","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bone.2022.116542_bb0275","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/jor.23440","article-title":"Osteoclast depletion with clodronate liposomes delays fracture healing in mice","volume":"35","author":"Lin","year":"2017","journal-title":"J. Orthop. Res."},{"issue":"3","key":"10.1016\/j.bone.2022.116542_bb0280","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/jor.23672","article-title":"Improved union and bone strength in a mouse model of NF1 pseudarthrosis treated with recombinant human bone morphogenetic protein-2 and zoledronic acid","volume":"36","author":"Deo","year":"2018","journal-title":"J. Orthop. Res."},{"issue":"4","key":"10.1016\/j.bone.2022.116542_bb0285","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00198-021-06208-7","article-title":"Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repair","volume":"33","author":"Saito","year":"2022","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2022.116542_bb0290","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/17453674.2014.916488","article-title":"Histology of 8 atypical femoral fractures: remodeling but no healing","volume":"85","author":"Schilcher","year":"2014","journal-title":"Acta Orthop."},{"key":"10.1016\/j.bone.2022.116542_bb0295","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.semarthrit.2014.09.005","article-title":"Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration","volume":"44","author":"Miller","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.bone.2022.116542_bb0300","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11914-018-0464-6","article-title":"Current understanding of epidemiology, pathophysiology, and management of atypical femur fractures","volume":"16","author":"Starr","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"issue":"2","key":"10.1016\/j.bone.2022.116542_bb0305","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bone.2010.05.015","article-title":"Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair","volume":"47","author":"Sloan","year":"2010","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bone.2022.116542_bb0310","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/jor.21464","article-title":"Bisphosphonate treatment delays stress fracture remodeling in the rat ulna","volume":"29","author":"Kidd","year":"2011","journal-title":"J. Orthop. Res."},{"issue":"4","key":"10.1016\/j.bone.2022.116542_bb5000","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis.","volume":"95","author":"Watts","year":"2010","journal-title":"J. Clin. Endocrinol. Metab"},{"issue":"3","key":"10.1016\/j.bone.2022.116542_bb5005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00223-011-9563-4","article-title":"Effect of dosing interval duration of intermittent ibandronate treatment on the healing process of femoral osteotomy in a rat fracture model","volume":"90","author":"Manabe","year":"2012","journal-title":"Calcif. Tissue Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222002198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222002198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:04:22Z","timestamp":1757613862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328222002198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":61,"alternative-id":["S8756328222002198"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2022.116542","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of bisphosphonates on appendicular fracture repair in rodents","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2022.116542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116542"}}